The glucose analog 2-deoxyglucose (2DG) inhibits the growth of Saccharomyces cerevisiae and human tumor cells, but its modes of action have not been fully elucidated. Yeast cells lacking Snf1 (AMP-activated protein kinase) are hypersensitive to 2DG. Overexpression of either of two low-affinity, high-capacity glucose transporters, Hxt1 and Hxt3, suppresses the 2DG hypersensitivity of snf1⌬ cells. The addition of 2DG or the loss of Snf1 reduces HXT1 and HXT3 expression levels and stimulates transporter endocytosis and degradation in the vacuole. 2DG-stimulated trafficking of Hxt1 and Hxt3 requires Rod1/Art4 and Rog3/ Art7, two members of the ␣-arrestin trafficking adaptor family. Mutations in ROD1 and ROG3 that block binding to the ubiquitin ligase Rsp5 eliminate Rod1-and Rog3-mediated trafficking of Hxt1 and Hxt3. Genetic analysis suggests that Snf1 negatively regulates both Rod1 and Rog3, but via different mechanisms. Snf1 activated by 2DG phosphorylates Rod1 but fails to phosphorylate other known targets, such as the transcriptional repressor Mig1. We propose a novel mechanism for 2DG-induced toxicity whereby 2DG stimulates the modification of ␣-arrestins, which promote glucose transporter internalization and degradation, causing glucose starvation even when cells are in a glucose-rich environment.
C ells sense and respond to changes in the nutrient supply to ensure optimal cell growth and survival. To achieve this adaptation, cell-signaling cues dictate compensatory alterations in the transcriptome and proteome (1) (2) (3) (4) (5) . The addition of the glucose analog 2-deoxyglucose (2DG) to cells causes a glucose starvation-like response, inhibiting growth and reducing viability even in the presence of abundant glucose (6, 7) . 2DG is taken up and converted to 2-deoxyglucose-6-phosphate (2DG-6P) (8, 9) ; however, the absence of a hydroxyl group on C-2 prevents the further catabolism of 2DG-6P by phosphoglucose isomerase. Accumulation of 2DG-6P may result in product inhibition of hexokinase, thereby inhibiting glycolysis (10) . In Saccharomyces cerevisiae, 2DG reportedly inhibits the biosynthesis of both cell wall polysaccharide and glycoprotein, causing cells to become osmotically fragile (11, 12) . Whether these are the only means by which 2DG short-circuits normal glucose utilization remains unclear.
Addressing this question is of significant clinical importance, because 2DG is a potent inhibitor of cancer cell proliferation. 2DG impedes cancer progression in animal models and continues to be assessed as an anticancer therapeutic (13) (14) (15) (16) . 2DG selectively inhibits cancerous cells as a result of a key metabolic shift that distinguishes many malignant cells from the surrounding normal tissues. Many tumor cells shunt glucose through the glycolytic pathway and use lactic acid fermentation to generate ATP, a phenomenon first recognized by Otto Warburg (17, 18) . In spite of the widespread use of 2DG, the mechanism by which it inhibits cell growth remains controversial; it has been reported to generate a dead-end metabolite in 2DG-6P that inhibits glycolytic flux, to reduce cellular ATP pools, and to impede proper protein glycosylation (6, 10, (19) (20) (21) .
Yeast cells share metabolic similarities with cancerous cells in that they ferment glucose in the presence of oxygen and exhibit sensitivity to 2DG, even when glucose is available (7, 22) . We have demonstrated that yeast cells lacking Snf1, the yeast ortholog of the catalytic subunit of mammalian AMP-activated protein kinase (AMPK), are hypersensitive to 2DG (7) . Both Snf1 and mammalian AMPK respond to the cellular energy status, becoming activated as the ratio of AMP and ADP to ATP rises (23, 24) . In yeast, active Snf1 is needed for cells to switch from using glucose to employing alternative carbon sources, such as sucrose or ethanol (25) . In agreement with observations in mammalian cells (26, 27) , treatment of yeast with 2DG increases Snf1 activity, as evidenced by increased phosphorylation of the conserved threonine in the activation loop (7) . Surprisingly, certain downstream effectors of Snf1 that are phosphorylated in response to glucose limitation are not detectably phosphorylated by Snf1 in response to 2DG (7) . These findings suggested that 2DG-stimulated Snf1 might be selectively targeted to previously uncharacterized downstream effectors. To identify these effectors, we screened a systematic overexpression library (28) for suppressors of the hypersensitivity of snf1⌬ cells to 2DG. In this way, we identified HXT1 and HXT3, which encode the low-affinity, high-capacity hexose transporters responsible for glucose uptake from a glucose-rich environment (29) (30) (31) , suggesting that the levels of Hxt1 and Hxt3 become ratelimiting for growth on glucose in snf1⌬ cells challenged with 2DG. We demonstrate here that the addition of 2DG inhibits the transcription of HXT1 and HXT3 and also downregulates Hxt1 and Hxt3 by stimulating their endocytosis and trafficking to the vacuole. Hxt1 and Hxt3 endocytosis in response to 2DG is consistent with recent studies showing that nutrient starvation also causes Hxt1 and Hxt3 endocytosis in a process that requires the ubiquitin ligase Rsp5 (32, 33) . Rsp5, a member of the Nedd4 ubiquitin ligase family, has a well-established role in regulating the trafficking of nutrient permeases and transporters in response to environmental changes (34) (35) (36) . Hxt1 and Hxt3, like many of the integral membrane proteins regulated by Rsp5, lack the PPXY motifs needed to recruit this ligase directly (35, 37) . Members of a recently described family of trafficking adaptors conserved from yeast to humans-known as the ␣-arrestins or, alternatively, as arrestin-related trafficking adaptors (ARTs)-each contain PPXY motifs, bind Rsp5 (or its mammalian counterparts), and recruit the ubiquitin ligase to specific membrane cargos (27, (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) . Two paralogous ␣-arrestins, Rod1/Art4 and Rog3/Art7, are required for 2DG-induced endocytosis and vacuolar trafficking of Hxt1 and Hxt3, and their Rsp5-binding motifs are needed for this process.
Collectively, our findings indicate that 2DG stimulates the endocytosis of Hxt1 and Hxt3 in an ␣-arrestin-dependent and Snf1-regulated manner. Moreover, given recent evidence that endocytosis of at least one mammalian glucose transporter (GLUT1) is under the control of an ␣-arrestin (thioredoxin-interacting protein [TXNIP] ) and AMPK (27) , our observations have important implications for better understanding of the mechanism of 2DG toxicity in cancer cell models.
MATERIALS AND METHODS
Yeast strains and growth conditions. All the yeast strains used in this study were derived from the S228C lineage. Most yeast strains with specific gene deletions were generated in our laboratories or by the Saccharomyces Genome Deletion Project (48) and were purchased from Thermo Scientific (Table 1) . EN60, a strain lacking nine arrestin genes (42), referred to below as the 9Arr⌬ strain, was kindly provided by Hugh Pelham (MRC Laboratory of Molecular Biology, Cambridge, United Kingdom). Cells were grown at 30°C using a standard synthetic complete medium lacking nutrients needed for plasmid selection (49) . The plasmids employed in this study are described in Table 2 .
Mutagenesis. Oligonucleotide-directed mutagenesis was performed with Pfu polymerase, followed by DpnI digestion of the plasmid template (50) . All of the mutations were confirmed by DNA sequencing. The constructs expressing Rod1-3HA and Rog3-3HA were the gift of Christopher Alvaro (UC Berkeley).
2-Deoxyglucose resistance assays. Resistance to 2DG was measured in liquid culture growth assays (7) . Fresh overnight cultures were diluted in fresh medium to an A 600 of 0.1 in the absence or presence of a range of 2DG concentrations: 0.01, 0.02, 0.05, 0.1, and 0.2 g/100 ml. Cells were grown for 18 h, and the final A 600 was measured. Cell growth was plotted relative to growth in the absence of 2DG, defined as 100%.
Immunoblotting. Yeast whole-cell extracts were prepared using the trichloroacetic acid (TCA) extraction method (51) . The Rod1 and Rog3 proteins tagged with the hemagglutinin (HA) epitope were detected with a 1:3,000 dilution of a mouse anti-HA antibody (Santa Cruz Biotechnology, Santa Cruz, CA). Green fluorescent protein (GFP)-tagged proteins were detected with a 1:1,000 dilution of a mouse anti-GFP antibody (catalog no. sc-9996; Santa Cruz Biotechnology). The secondary antibody was DyLight 680-conjugated goat anti-mouse IgG (Thermo Scientific, Waltham, MA) diluted 1:10,000. Blots were normalized by using Sec61 as the control protein, detected with an affinity-purified anti-Sec61 primary antibody at 1:1,000 (a gift of Jeffrey Brodsky, Department of Biological Sciences, University of Pittsburgh) followed by an IRDye 800CW-conjugated goat anti-rabbit secondary antibody (Li-Cor, Lincoln, NE) diluted 1:10,000. For phosphatase treatments, yeast whole-cell extracts were treated with calf intestinal alkaline phosphatase (CIP; New England BioLabs, Ipswich, MA) for 1 h at 37°C, followed by TCA precipitation. Rod1-3HA was immunoprecipitated from whole-cell extracts by using an agarose-conjugated anti-HA antibody (Santa Cruz), and ubiquitinated species were detected with a mouse antibody against ubiquitin (Ub) (catalog no. sc-8017; Santa Cruz) followed by DyLight 680-conjugated goat anti-mouse IgG (Thermo Scientific). Blots were scanned using an infrared scanner (Odyssey; Li-Cor). The integrated intensities of bands were quantified by using scanning software supplied by the manufacturer (Li-Cor). LacZ assays. To assess the levels of expression of reporter genes whose promoters were fused to Escherichia coli lacZ, yeast cells were grown to mid-exponential phase in a high-glucose medium either alone or with 0.05% 2DG and were lysed by vortex mixing with glass beads. Samples of the resulting extracts were assayed for ␤-galactosidase activity in triplicate (52) . Fluorescence microscopy. The GFP-tagged glucose transporters Hxt1 and Hxt3 were imaged using an inverted Ti Eclipse swept-field confocal microscope (Nikon, Chiyoda, Tokyo, Japan; Prairie Instruments, Middleton, WI) fitted with an Apo 100ϫ objective (numerical aperture, 1.49). Images were captured using an electron-multiplying charge-coupled device camera (iXon3; Andor, Belfast, United Kingdom) and NIS-Elements software (Nikon). The day before imaging, cells were grown overnight to saturation in selective, synthetic complete medium at 30°C. The cells were diluted the next morning into fresh medium and were regrown to midexponential phase (A 600 , 0.5); then either 0.2% glucose or 0.2% 2DG was added. The cells were incubated further at 30°C for 0 to 120 min, as indicated in the figures, prior to imaging. For experiments where cells were treated with latrunculin A (Lat A), cultures were grown to earlyexponential phase (A 600 , 0.3), treated for 90 min either with an equivalent volume of the solvent (dimethyl sulfoxide [DMSO]) alone or with 200 M (final concentration) Lat A (Life Technologies, Carlsbad, CA) from a stock dissolved in DMSO, and then further incubated with 0.2% 2DG for 90 min at 30°C. Prior to imaging, cells in the Lat A experiments were stained with FM 4-64 (see below) to assess the degree of inhibition of endocytosis. Cells were plated onto glass-bottom dishes (MatTek, Ashland, MA) coated with concanavalin A (Sigma, St. Louis, MO) and were allowed to settle for 5 min prior to imaging. Prior to imaging, cells in the RSP5 and rsp5-1 backgrounds were grown at a permissive temperature (23°C) from an A 600 of 0.2 for 4 h and were shifted to a restrictive temperature (37°C) for 30 min prior to 2DG addition. All images from an experiment were captured with identical imaging parameters and were equivalently adjusted using Adobe Photoshop software. For most figures, an unsharp mask filter was applied to the images with a threshold of 5 levels and a pixel radius of 3.
Vacuolar staining. To visualize vacuoles, cells were incubated with 250 M CellTracker Blue CMAC (7-amino-4-chloromethylcoumarin) dye (Life Technologies, Carlsbad, CA) for 15 to 30 min. Cells were then pelleted, washed, and resuspended prior to imaging. As a control in the Lat A experiments, cells were costained with FM 4-64 (53) by first incubating the cells in a medium with 1.6 M FM 4-64 for 20 min, then pelleting them, resuspending them in fresh medium without FM 4-64 but containing DMSO, Lat A, and/or 2DG, and finally incubating them for a further 15 min (to allow time for dye internalization) before imaging.
Fluorescence quantification. The fluorescence intensities of Hxt1-GFP and Hxt3-GFP were quantified using ImageJ software (NIH, Bethesda, MD). For the quantification of fluorescence at the cell surface, the plasma membrane (PM) in each of at least 150 cells was manually outlined using ImageJ software, mean pixel intensity measured, and mean background pixel intensity subtracted (43) . The distribution of mean pixel intensities (in arbitrary units) and the distribution of pixel intensities for each cell population are presented as box-and-whisker plots. Nonparametric, two-tailed Mann-Whitney U tests were performed using Prism software (GraphPad, La Jolla, CA), and statistically significant differences are indicated in figures by using asterisks as described in the next section. For the quantification of fluorescence in the vacuole, vacuole profiles revealed by CMAC dye were used to generate a mask in ImageJ, which was then overlaid on the Hxt1-GFP or Hxt3-GFP image; the GFP signal congruent with the vacuole was measured; and mean background fluorescence intensity was subtracted. Each vacuole identified in a given field was then paired with a corresponding measurement of PM fluorescence, performed as described above. Prism software and nonparametric, two-tailed Mann-Whitney U tests were used to assess the significance of changes in the vacuole fluorescence distribution and PM/vacuolar fluorescence ratios. When three or more comparisons were made across groups (see, e.g., Fig. 4I and J), rather than the Mann-Whitney U test, we used one-way analysis of variance (ANOVA) with the nonparametric Kruskal-Wallis test and Dunn's multiple-comparison post hoc analyses using Prism software. In the absence of a vacuolar costain, the ratio of PM fluorescence to intracellular fluorescence was determined by manually contouring PMs and then pairing each with a measure of total intracellular fluorescence, assigned manually using ImageJ software. Since the vast majority of intracellular fluorescence arises from the vacuole in these cells, this PM/intracellular fluorescence ratio is representative of the approximate PM/vacuole ratio.
Statistical significance. For all bar plots, each mean value represents the average for a minimum of three independent measurements, and the error bars represent 1 standard error. Statistical significance was determined using the Student t test for unpaired variables with equal variance.
RESULTS

HXT1
and HXT3 are dosage suppressors of the 2DG hypersensitivity of snf1⌬ cells. Yeast cell growth is inhibited by low concentrations of 2DG. We and others have shown that sensitivity to 2DG differs depending on the carbon source (7, 12) . We found that cells growing on glucose were the most resistant and those growing on a nonfermentable carbon source (glycerol/ethanol) were the most sensitive (7) . Strikingly, we also found that cells lacking Snf1 exhibit a 2DG-hypersensitive phenotype, even when growing on glucose. To gain insight into the 2DG-hypersensitive phenotype of snf1⌬ cells and the mechanism of action of 2DG, we transformed snf1⌬ cells with a systematically constructed, comprehensive genomic DNA library in a multicopy vector (28) and selected for clones that conferred a growth advantage on the snf1⌬ cells in glucose medium containing 0.01% 2DG. As expected, we recovered the clone overexpressing Snf1 (not shown). In addition, we isolated multiple clones that carried hexose transporter genes. Strong suppression of the 2DG hypersensitivity of snf1⌬ cells was observed with three plasmids, one carrying HXT1 and HXT4, one carrying HXT3 and HXT6, and one carrying HXT3 alone. Subclones generated in the high-copy-number plasmid pRS425 demonstrated that the HXT1 and HXT3 genes, not the HXT4 or HXT6 gene, were responsible for the suppression (not shown). The inability of HXT4 to suppress the 2DG-hypersensitive phenotype of snf1⌬ cells was not due to lack of expression, since Hxt4-GFP overexpressed from a high-copy-number plasmid was detected at the cell surface (not shown).
Given these findings, we tested directly all library clones that contained a hexose transporter gene(s) for their abilities to ameliorate the 2DG hypersensitivity of snf1⌬ cells. In agreement with the results of our screen, only clones containing HXT1 or HXT3 were strong suppressors (Fig. 1) . Overexpression of HXT2 weakly suppressed the 2DG-hypersensitive phenotype, but this suppression was not strong enough to have been detected in our original screen.
Earlier selections for dosage suppressors that confer 2DG resistance were conducted in SNF1 ϩ cells and identified the DOG1 and DOG2 genes, linked paralogs encoding enzymes with 2DG-6P phosphatase activity (54) . Dog1 and Dog2 confer 2DG resistance on cells growing on alternative carbon sources by preventing the accumulation of 2DG-6P, presumably alleviating the inhibition of glycolysis. Hence, we compared the effect of DOG1 and DOG2 overexpression with that of HXT1 on the 2DG resistance of wildtype cells in either glucose-or sucrose-containing medium and on that of snf1⌬ cells in glucose medium (cells lacking Snf1 are unable to grow on sucrose). In glucose-grown snf1⌬ cells, HXT1 overexpression conferred a strong growth advantage over a wide range of 2DG concentrations, whereas DOG1 and DOG2 overexpression had no discernible effect ( Fig. 2A) . When the same comparison was conducted in wild-type (SNF1 ϩ ) cells, DOG1 and DOG2 overexpression conferred significant 2DG resistance, whereas HXT1 overexpression had a more modest effect (Fig. 2B) . Wild-type cells grown on sucrose are more sensitive to 2DG than cells grown on glucose (7) . On this carbon source, DOG1 and DOG2 overexpression conferred a readily detectable growth advantage in the presence of 2DG (Fig. 2C) , whereas HXT1 did not, presumably because HXT1 is poorly expressed in the absence of glucose (29) . These results suggested that snf1⌬ cells have defects in hexose transporter expression, localization, and/or function that cannot be ameliorated by the action of Dog1 and Dog2.
2DG reduces Hxt1 and Hxt3 expression and protein levels and stimulates trafficking to the vacuole. To assess HXT1 and HXT3 transcription in response to 2DG, we employed HXT promoter-lacZ fusions, which have been used to evaluate the carbon source-dependent expression patterns of hexose transporters (29) . In wild-type cells, HXT1 and HXT3 expression was significantly decreased upon 2DG addition (Fig. 3A and B) . In snf1⌬ cells, basal HXT1 and HXT3 expression was lower than in wildtype cells and was further dampened upon 2DG addition. These findings demonstrate that Snf1 function is required for optimal HXT1 and HXT3 expression on glucose and also that one previously uncharacterized effect of 2DG is to impede the expression of these transporter genes. Loss of Reg1 greatly reduced HXT1 and HXT3 expression in either the absence or the presence of 2DG (Fig. 3A and B) . Reg1 is the regulatory subunit of Glc7, the type 1 protein phosphatase (PP1) responsible for the dephosphorylation and inactivation of Snf1 (55) (56) (57) . In reg1⌬ cells, Snf1 is constitutively phosphorylated and active (58, 59) , and therefore, one might have expected reg1⌬ cells to display the opposite phenotype from snf1⌬ cells. Since this is not the case, our results suggest that some other Reg1-dependent PP1 action is required for the transcription of the HXT1 and HXT3 genes. In any event, the effects observed on HXT1 and HXT3 at the transcriptional level were reflected in the steady-state levels of the proteins encoded, with (i) reduced Hxt1 and Hxt3 levels in wild-type cells after 2DG addition, (ii) lower Hxt1 and Hxt3 levels in snf1⌬ cells than in wildtype cells and further reduction upon 2DG addition, and (iii) al- were prepared from wild-type, snf1⌬, and reg1⌬ cells with a chromosomal HXT1-GFP or HXT3-GFP gene, with or without 2DG, for 2 h. Proteins were analyzed by immunoblotting, and the mean Hxt-GFP/Sec61 ratios Ϯ standard errors from triplicate samples were plotted. (E and F) Wild-type, snf1⌬, and reg1⌬ cells containing either Hxt1-GFP, expressed from the endogenous HXT1 promoter or from the ADH1 promoter (E), or a chromosomal HXT3-GFP gene (F) were examined after 2 h of treatment with 0.2% glucose (no drug) or 0.2% 2DG. (G and H) The PM and intracellular GFP fluorescence intensities from the cells depicted in panels E and F, respectively, were quantified, and the distributions of the PM/intracellular GFP fluorescence ratios were plotted (n, Ͼ110 cells). The horizontal midline represents the median; the box is bounded by the upper and lower quartiles; and the whiskers denote the maximal and minimal fluorescence intensities. *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001; NS or ns, P Ͼ 0.05. most no detectable Hxt1 and reduced Hxt3 levels in reg1⌬ cells (Fig. 3C and D) .
We next examined the localizations of Hxt1-GFP and Hxt3-GFP. In wild-type cells in a high-glucose medium, both proteins displayed a prominent signal at the PM with variable fluorescence in the vacuole, whereas by 2 h after the addition of 2DG, the PM fluorescence for Hxt1 and Hxt3 was substantially reduced, while vacuolar fluorescence was dramatically increased (Fig. 3E and F) . These observations are further supported by quantification of the PM/intracellular fluorescence ratio (Fig. 3G and H) , which was significantly decreased upon 2DG addition and was lower in snf1⌬ cells than in wild-type cells under either the basal condition or 2DG treatment. Thus, exposure to 2DG appears to stimulate the internalization of Hxt1 and Hxt3. In the absence of Snf1, the 2DG-stimulated internalization of Hxt1 and Hxt3 was even more pronounced ( Fig. 3E to H) , suggesting that Snf1 inhibits the endocytosis and/or vacuolar trafficking of these transporters. In agreement with the drastically reduced HXT1 expression observed in reg1⌬ cells (Fig. 3A and C) , it was difficult to detect this transporter (Fig. 3E) . Additionally, Hxt3-GFP fluorescence is reduced in reg1⌬ cells, with considerable vacuolar fluorescence even before 2DG addition (Fig. 3F ). These changes in Hxt1 and Hxt3 protein levels and localization are not strictly due to alterations in gene expression, however, since Hxt1-GFP expressed from the strong constitutive ADH1 promoter exhibited similar protein abundance and localization changes in response to 2DG (Fig. 3E, bottom) . These data indicate that Snf1, Reg1, and 2DG control Hxt transcription, abundance, and localization.
We followed the localization of Hxt1-GFP and Hxt3-GFP in response to 2DG treatment during a more detailed time course and used a dye (CMAC blue) that marks the vacuole to confirm that the observed intracellular fluorescence was vacuole associated. We found that: (i) in glucose-grown cells in the absence of 2DG, the majority of Hxt1 (Fig. 4A) and Hxt3 (Fig. 4B ) resided at the cell surface; (ii) within 20 min after exposure to 0.2% 2DG, dim vacuolar fluorescence was observed; (iii) during the course of incubation, vacuolar fluorescence increased continuously and in an increasing proportion of the cells; and (iv) conversely, PM fluorescence was progressively diminished over the course of the incubation (Fig. 4C and D) , with a concomitant increase in vacuolar fluorescence (Fig. 4E and F) .
To confirm that the increase in vacuolar fluorescence caused by 2DG treatment was due to endocytosis, we preincubated cells with Lat A and then treated them with 2DG. Lat A prevents actin polymerization and blocks endocytosis while leaving intracellular vesicle-mediated sorting intact (60) . As a control to determine the effectiveness of the Lat A block to endocytosis, cells in the same assay were costained with FM 4-64, a lipophilic dye that binds the PM but then is rapidly concentrated in the vacuolar membrane when endocytosis is functional (53); as expected, FM 4-64 remained predominantly at the surfaces of Lat A-treated cells, whereas in vehicle (DMSO)-treated cells, FM 4-64 was confined to the limiting membrane of the vacuole (data not shown). When cells expressing Hxt1-GFP or Hxt3-GFP were pretreated with Lat A, they no longer exhibited reduced PM fluorescence in response to 2DG (Fig. 4G, H, I , and J), demonstrating that 2DG stimulates the endocytosis of Hxt1 and Hxt3. However, even in Lat A-treated cells, vacuolar fluorescence increased after 2DG addition ( Fig. 4G  and H) , suggesting that 2DG may also divert Hxt1-GFP and Hxt3-GFP from the Golgi compartment or another intracellular compartment to the vacuole.
Endocytosis of Hxt1 and Hxt3 stimulated by 2DG requires the ␣-arrestins Rod1 and Rog3. The internalization and trafficking to the vacuole of many nutrient transporters are regulated by ␣-arrestins (38, 40, 42, 43, 45, 47, 61) . These proteins facilitate protein sorting by serving as adaptors that recruit the ubiquitin ligase Rsp5 to select cargos. We suspected that ␣-arrestins might be involved in the 2DG-stimulated internalization of Hxt1 and Hxt3 for three reasons. First, Rod1, one of the 13 known yeast ␣-arrestins, has been shown to regulate the glucose-stimulated endocytosis of hexose transporter Hxt6 (42) . Second, this ␣-arrestin is phosphorylated by Snf1 (62), which negatively regulates Rod1-mediated endocytosis of the lactate permease Jen1 (38) . Finally, a mammalian ␣-arrestin involved in downregulating the glucose transporter GLUT1 is also negatively regulated by AMPK (27) . We sought to determine if the 2DG-induced trafficking of Hxt1 and Hxt3 was regulated by ␣-arrestins. Indeed, in a mutant strain (9Arr⌬) lacking 9 of the 13 ␣-arrestins (42), 2DG no longer triggered the internalization of Hxt1-GFP or Hxt3-GFP ( Fig. 5A  and B) , and the reductions in the steady-state levels of Hxt1 and Hxt3 observed in wild-type cells treated with 2DG were prevented ( Fig. 5C and D) .
To determine whether any of the 9 ␣-arrestins missing in 9Arr⌬ cells were sufficient for 2DG-stimulated Hxt1-GFP and/or Hxt3-GFP endocytosis, the mutant was complemented with plasmids expressing each of these nine genes. For Hxt1-GFP, only ROD1 expression restored 2DG-stimulated internalization and vacuolar trafficking (Fig. 5E) , whereas for Hxt3-GFP, either ROD1 or its paralog ROG3 could do so potently, and CSR2 could do so only very weakly (Fig. 5F ). Indeed, Rod1 appears to be responsible for the 2DG-stimulated endocytosis of Hxt1-GFP, because Hxt1-GFP internalization after 2DG addition was ablated in rod1⌬ cells but was not markedly diminished in rog3⌬ cells (Fig. 6A ). In contrast, Hxt3-GFP internalization in response to 2DG was significantly reduced in rod1⌬ cells and not at all in rog3⌬ cells but was totally prevented in a rod1⌬ rog3⌬ double mutant (Fig. 6B) . Interestingly, in the absence of Rog3, the removal of Hxt3-GFP from the cell surface and its accumulation in the vacuole appeared to be greatly enhanced (Fig. 6B) , suggesting that the endocytosis of this transporter mediated by Rod1 (or perhaps another ␣-arrestin) is increased in the absence of Rog3. These data demonstrate new and distinct roles for Rod1 and Rog3 in regulating the trafficking of hexose transporters.
Snf1 negatively regulates Rod1-and Rog3-dependent endocytosis of Hxt1 and Hxt3. In cells lacking Snf1, basal and 2DG-induced vacuolar accumulation of Hxt1-GFP was elevated, but these effects were almost completely eliminated in snf1⌬ cells that also lacked Rod1 and Rog3 (Fig. 6C) . This epistasis suggests that with respect to hexose transporter trafficking, a primary function of Snf1 is to negatively regulate Rod1 and Rog3. Growth experiments supported this conclusion; the 2DG hypersensitivity of snf1⌬ cells was substantially rescued by the removal of Rod1 alone (Fig. 6D) , and growth was further enhanced by the removal of both Rod1 and Rog3 (Fig. 6E) but not by the removal of Rog3 alone (Fig. 6D) . Even the growth of wild-type cells in the presence of 2DG was increased by removal of both Rod1 and Rog3 (Fig.  6E) . These findings strongly suggest that the inhibition of cell growth on a glucose medium after challenge with 2DG is due primarily to the ␣-arrestin-mediated downregulation of Hxt1 and Hxt3. It has been reported that Snf1 phosphorylates Ser447 in Rod1 (62) . To determine whether modification at Ser447 alone is sufficient to explain how the action of Snf1 impedes Rod1-mediated internalization of Hxt1 and Hxt3, we generated and tested both a rod1(S447A) and a rod1(S447E) allele. We found that both of these mutants supported basal and 2DG-stimulated Hxt1-GFP and Hxt3-GFP endocytosis comparably to wild-type Rod1 (Fig.  6F ) and also restored sensitivity to 2DG equivalently to wild-type Rod1 (Fig. 6G) . Hence, Ser447 is not an important site, or not a sufficient site, for the Snf1-dependent regulation of Rod1. Indeed, more-recent phosphoproteomic studies have identified 31 phosphorylation sites on Rod1 by mass spectroscopy (63) (64) (65) (66) . Whether any of these sites are phosphorylated by Snf1 and regulate Rod1 function will be important to determine in subsequent studies.
For Rod1-mediated internalization of another PM client, the G protein-coupled receptor (GPCR) Ste2, Rod1 must be dephosphorylated by the yeast protein phosphatase 2B calcineurin (67) . Calcineurin is a Ca 2ϩ /calmodulin-stimulated enzyme with two alternative catalytic subunits, Cna1 and Cna2, and an essential regulatory subunit, Cnb1 (68) . However, we observed 2DG-stimulated Hxt1-GFP and Hxt3-GFP endocytosis even in cnb1⌬ cells (data not shown); hence, calcineurin-dependent dephosphorylation of Rod1 is not required for the internalization of these transporters. Therefore, the phosphoregulation of ␣-arrestins The mean PM fluorescence intensities of Hxt1-GFP or Hxt3-GFP before and 120 min after 0.2% 2DG addition were measured, and the distributions of these intensities were plotted. (E and F) The ratio of cell surface fluorescence to vacuolar fluorescence for Hxt1-GFP or Hxt3-GFP was determined (n, Ͼ150 cells), and the distributions of these ratios were plotted. (G and H) Wild-type cells with integrated Hxt1-GFP or Hxt3-GFP were imaged after treatment with either 200 M latrunculin A or the vehicle control DMSO for 2 h, followed by incubation with 0.2% 2DG for 90 min. (I and J) The PM intensities of Hxt1-GFP or Hxt3-GFP were measured (n, Ͼ110 cells), and the distributions were plotted. a.u., arbitrary units. For the box plots in panels C, D, E, F, I, and J, the horizontal midline in each box represents the median, the box is bounded by the upper and lower quartiles, and the whiskers denote the maximal and minimal fluorescence intensities. **, P Ͻ 0.01; ***, P Ͻ 0.001. is complex, with multiple kinases and phosphatases controlling ␣-arrestin function.
Rod1 and Rog3 must recruit Rsp5 to downregulate Hxt1 and Hxt3. The ␣-arrestins contain PPXY motifs (and variants thereof, such as LPXY or VPXY), which bind the WW domains in the ubiquitin ligase Rsp5 (35, 69) . This interaction recruits Rsp5 to specific cargos (37, 40, 42) . In turn, Rsp5-mediated ubiquitination of nutrient transporters at the cell surface is a prelude to their endocytosis (35, (70) (71) (72) (73) . It has been reported recently that Rsp5 is required for Hxt1 and Hxt3 turnover in response to nutrient starvation (32, 33) . Hxt1 and Hxt3 do not possess any PPXY or related motifs, as would be expected if the ␣-arrestins Rod1 and Rog3 served to deliver Rsp5 to these clients. Because mutation of the two PPXY sites in Rod1 or of two PPXY sites plus one VPXY site in Rog3 (Fig. 7A) abrogates their Rsp5 binding (38, 67) , we used our growth and fluorescence microscopy assays to assess the abilities of these mutants to support 2DG-stimulated internalization of Hxt1 and Hxt3. Unlike wild-type ROD1 and ROG3, rod1-PPXYless and rog3-V/PPXY-less were unable to confer 2DG sensitivity (Fig. 7B ) and failed to promote the internalization of either Hxt1- GFP or Hxt3-GFP upon 2DG addition (Fig. 7C) . Similarly, in cells where the hypomorphic rsp5-1 allele is present, 2DG fails to induce the endocytosis of Hxt1 (data not shown) or Hxt3 (Fig. 7E) , and the Hxt3-GFP protein is stabilized (Fig. 7F ) when cells are incubated at a restrictive temperature. Together, these data demonstrate that Rsp5 is required for the 2DG-stimulated and Rod1-and Rog3-mediated endocytosis of Hxt1 and Hxt3.
The formation of cargo-␣-arrestin-Rsp5 ternary complexes permits not only the ubiquitination of the cargo but also the ubiquitination of the ␣-arrestin. For some, but not all, ␣-arrestin- (84) . The positions of the Rsp5 binding sites (VPXY and PPXY motifs), the putative Snf1-dependent phosphorylation site at S447, and the 4 conserved lysine residues that are changed to arginine (4KR sites) in order to block ubiquitination (38, 67) are indicated. (B) Wild-type or rod1⌬ rog3⌬ cells were transformed with the indicated plasmids and were assayed for sensitivity to 0.1% 2DG. Mean values from triplicate samples Ϯ standard errors were plotted. (C and D) Wild-type or rod1⌬ rog3⌬ cells containing integrated Hxt1-GFP or Hxt3-GFP and transformed with the indicated plasmids were imaged before (no drug) or after a 2-h treatment with 0.2% 2DG. (E) Wild-type or rsp5-1 cells containing integrated Hxt3-GFP were imaged before (no drug) or after a 2-h treatment with 0.2% 2DG at 37°C. (F) Protein extracts were prepared in triplicate from cells treated as in the experiment for which results are shown in panel E. The extracts were assessed by immunoblotting with anti-GFP and anti-Sec61 antibodies. The mean ratios of Hxt3-GFP to Sec61 Ϯ standard errors were plotted. *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001; ns, P Ͼ 0.05. cargo pairs, ubiquitination of the ␣-arrestins is required for their endocytic function (38, 40, 45, 67) . Rod1 ubiquitination has been mapped to 4 lysine residues within the arrestin domain, which are perfectly conserved in Rog3 (Fig. 7A) (38, 67) . When these residues in Rod1 are mutated to arginine, the resulting Rod1(4KR) mutant is able to bind Rsp5 but is no longer ubiquitinated (38, 67) . In contrast to the requirement for Rsp5 binding, rod1-4KR and rog3-4KR behaved as hypomorphic alleles. While Rod1-4KR stimulated some vacuolar trafficking of Hxt1 and Hxt3 in response to 2DG, PM fluorescence was retained to a greater degree than was observed with wild-type Rod1 (Fig. 7D) . Supporting the idea that Hxt1 and Hxt3 are retained at the PM, cells expressing Rod1-4KR displayed greater 2DG resistance than cells expressing wild-type Rod1 (Fig. 7B) . Similarly, Rog3-4KR also conferred a somewhat higher degree of 2DG resistance than wild-type Rog3 (Fig. 7B) ; however, no discernible difference in Hxt localization was apparent (Fig. 7D) . Thus, recruitment of Rsp5 is necessary and sufficient for Rod1 to promote the endocytosis of Hxt1 and Hxt3, presumably by ubiquitinating these transporters, but the ␣-arrestins themselves need not be ubiquitinated at these four conserved lysine residues in order to promote glucose transporter trafficking.
Posttranslational modification of Rod1 and Rog3 is altered in response to 2DG. Considerable evidence indicates that ␣-arrestins are regulated by phosphorylation and ubiquitination (38, 40, 41, 43, 45, 61, 67, 74) . Both Rod1 and Rog3 were detectably phosphorylated when they were extracted from wild-type cells growing on glucose, as judged by the presence of a slower-migrating band(s) that collapsed after treatment with calf intestinal alkaline phosphatase (CIP) (Fig. 8A and B, lanes 1 and 2) . Upon 2DG addition, phosphorylated species increased and a new, CIPresistant, slower-migrating band appeared for both Rod1 and Rog3 (Fig. 8A and B, lanes 1 and 3) . Immunoprecipitation of HA-tagged Rod1 from wild-type cells before and after treatment with 2DG, followed by blotting with an antiubiquitin antibody, confirmed that the slowest-migrating bands were ubiquitinated Rod1 (Fig. 8C, lanes 1 and 2) .
For Rod1 in both the absence and the presence of 2DG, the phosphorylated forms were largely eliminated in snf1⌬ cells (Fig.  8A , lanes 5 to 8, and E) and were markedly increased in reg1⌬ cells, in which Snf1 is hyperactive (58, 59) (Fig. 8A, lanes 9 to 12) ; thus, the 2DG-stimulated increase in Rod1 phosphorylation is largely Snf1 dependent. Rod1 itself may be a substrate of the Reg1-containing isoform of PP1 (38) , and hence, the elevated modification of Rod1 observed in reg1⌬ cells could be enhanced by inefficient dephosphorylation. The increase in Rod1 ubiquitination caused by 2DG was somewhat reduced in snf1⌬ cells (Fig. 8A) . However, The abundance of Rog3-3ϫHA protein was examined in cells of the indicated genotypes that were either left untreated or treated with 0.2% 2DG. The abundance of Rog3 was normalized to that of Sec61, and the mean ratios from triplicate samples Ϯ standard errors were plotted. Representative blots are shown below the graph. (E) The phosphorylation of Rod1-3ϫHA protein was examined in wild-type and snf1⌬ cells either left untreated or treated with 0.2% 2DG. The abundance of Rod1-P was normalized to that of Sec61, and the mean ratios from triplicate samples Ϯ standard errors were plotted. Representative blots are shown on the left of the graph. *, P Ͻ 0.05; ns, P Ͼ 0.05.
we noted that in contrast to the pattern in wild-type cells, Rod1 was detectably ubiquitinated in snf1⌬ cells even in the absence of 2DG treatment, and conversely, Rod1 was not ubiquitinated in reg1⌬ cells either in the absence or in the presence of 2DG (Fig.  8C) . These data are most consistent with a role for Snf1-dependent phosphorylation in preventing Rod1 ubiquitination.
Rog3 phosphorylation was also enhanced by 2DG addition, although it was not clear if the phosphorylation was Snf1 dependent. The slower-migrating Rog3 species appeared as a diffuse smear rather than distinct bands, hindering analysis (Fig. 8B) . Nonetheless, it is clear that Rog3 was phosphorylated, because CIP treatment collapsed most of the diffusely migrating species into the single fastest-migrating band. Moreover, a readily detectable, slower-migrating, CIP-resistant Rog3 band(s) (Fig. 8B, asterisks) appeared in wild-type or snf1⌬ cells in response to 2DG treatment. Rog3 protein levels in cells were noticeably higher after 2DG treatment ( Fig. 8B and D) . In contrast to the effect on Rod1, the hyperactive Snf1 in reg1⌬ cells caused a dramatic reduction in Rog3 abundance ( Fig. 8B and D) . Furthermore, Rog3 abundance is regulated by Snf1, since Rog3 levels were restored in a reg1⌬ strain if Snf1 was absent (Fig. 8D) . These results show that at some level (expression and/or protein stability), Rog3 is negatively regulated by Snf1. Thus, Rod1 and Rog3 appear to be subject to different regulatory inputs both before 2DG treatment and in response to 2DG, presumably allowing for physiologically appropriate finetuning of their combined activities.
DISCUSSION
Prior studies have proposed a number of explanations for 2DG-induced toxicity, including accumulation of 2-deoxyglucose-6-phosphate as a metabolic inhibitor of glycolysis, reduction of cellular ATP pools, elevation of NADH levels, accumulation of defects in cell wall biogenesis, and disruption of protein glycosylation (6, 11, 20, 75, 76) . Here we have documented that 2DG also reduces the expression and cell surface abundance of two glucose transporters, Hxt1 and Hxt3. To our knowledge, our findings are the first demonstration that the trafficking of glucose transporters to the vacuole markedly increases in response to 2DG, and they help to explain the observation that 2DG acts as a glucose starvation mimetic (77) . Our data indicate that in addition to acting as a competing and nonproductive glucose analog, 2DG severely limits glucose entry by dampening transcription and stimulating the removal of Hxt1 and Hxt3 from the PM. Together, these effects reveal how 2DG causes a failure to proliferate even when exogenous glucose is abundant.
In our study, we also elucidated the mechanism of the 2DG-induced trafficking of Hxt1 and Hxt3. 2DG-stimulated internalization of Hxt1 and Hxt3 requires the action of two trafficking adaptors, ␣-arrestins Rod1 and Rog3, which deliver the ubiquitin ligase Rsp5 to these two hexose transporters, ostensibly to stimulate their ubiquitination and thereby mark them for endocytic removal. Furthermore, our data indicate that the function of Rod1 is negatively regulated by Snf1-dependent phosphorylation. When 2DG is present, Snf1 activation helps to counteract the Rod1-and Rog3-mediated internalization of Hxt1 and Hxt3 in an attempt to maintain some degree of glucose uptake. Rog3 shares 38 to 41% sequence identity (depending on alignment gaps) over its length with Rod1 (40, 42) . Indeed, in the regulation of at least one other cargo, the GPCR Ste2, Rod1 and Rog3 play semiredundant roles (67) . However, our analyses revealed some previously unrecognized distinctions between these two ␣-arrestins. First, Rod1 seems to be the adaptor solely responsible for Hxt1 internalization in response to 2DG, while Hxt3 endocytosis in response to 2DG was fully ablated only by the absence of both Rod1 and Rog3. Second, we found that Rod1 is a target for Snf1-dependent phosphorylation in response to 2DG, in agreement with prior observations that Rod1 is phosphorylated in a Snf1-mediated manner when glucose is limiting (38, 62) . While the role of Snf1 in Rog3 phosphorylation was less clear, Snf1 plays a critical role in regulating Rog3 abundance. Also, we found that one Snf1 phosphorylation site in Rod1 characterized by others (62) is clearly not sufficient to affect Rod1 activity on Hxt1 and Hxt3. Third, both Rod1 and Rog3 need to associate with Rsp5 in order to bring about Hxt internalization in response to 2DG.
We propose a model (Fig. 9A ) whereby under glucose-rich growth conditions, Snf1 activity is low (7, 58) but nonetheless important for the efficient uptake and utilization of glucose. Under these conditions, Snf1 selectively phosphorylates Rod1 to inhibit Rod1-mediated turnover of Hxt1 and Hxt3, thereby maintaining high-capacity glucose transporter activity at the surface. This model is supported by our observations that (i) Rod1 is phosphorylated in a Snf1-dependent manner even in the presence of glucose; (ii) Hxt1 and Hxt3 internalization is increased in snf1⌬ cells; and (iii) deletion of ROD1 prevents the endocytosis of Hxt1 and Hxt3.
Rod1 regulation of Hxt trafficking is controlled by a variety of posttranslational modifications (Fig. 9B) . In the absence of Snf1 or when 2DG is added to the growth medium, Rod1 ubiquitination is dramatically increased. 2DG activates Snf1 (7), promotes Rod1 phosphorylation and ubiquitination, and greatly stimulates the trafficking of Hxt1 and Hxt3 to the vacuole. These data suggest that Snf1-mediated phosphorylation may both inhibit and activate the Rod1-regulated trafficking of hexose transporters. We envision two possible regulatory models. (i) The degree of Snf1-mediated phosphorylation of Rod1 dictates the response. In glucose-grown cells, low-level Snf1 activity and the phosphorylation of Rod1 inhibit Rod1 ubiquitination and Rod1-mediated trafficking of hexose transporters. Increased Snf1 activity due to 2DG addition leads to hyperphosphorylation of Rod1, increased ubiquitination, and increased trafficking of Hxt1 and Hxt3 (Hxt1/3) to the vacuole. (ii) Alternatively, Snf1 phosphorylation of Rod1 is always inhibitory, but a yet-to-be-identified, counteracting regulatory element becomes more active and drives the Rod1 equilibrium toward the ubiquitinated and Rsp5-bound form, capable of stimulating the endocytosis of Hxt1 and Hxt3 (Fig. 9B) . Indeed, Reg1 could serve as the counterbalance to Snf1 in the latter scenario. Reg1 interacts with Rod1 and reduces Rod1 phosphorylation (38) , in agreement with the observed hyperphosphorylation and lack of ubiquitination of Rod1 in the absence of Reg1. However, the elucidation of the role of Reg1 in controlling the ␣-arrestin-mediated trafficking of hexose transporters in response to 2DG is somewhat confounded by the fact that in the absence of Reg1, neither Hxt1 nor Hxt3 is well expressed. It is clear that Reg1 stimulates Rod1 dephosphorylation, either directly (by targeting the Glc7 phosphatase to Rod1), indirectly (by downmodulating Snf1 itself), or both. Rod1 is not detectably ubiquitinated in reg1⌬ cells, suggesting that hyperphosphorylation of Rod1 inhibits its recruitment of Rsp5 and/or its ubiquitination, as has been proposed previously (38) .
Rod1 ubiquitination, and likely Rog3 ubiquitination, was in-creased following 2DG treatment. While Rod1 and Rog3 ubiquitination is important, it is not absolutely required for Rod1-or Rog3-mediated trafficking of Hxt1/3 to the vacuole. Mutation of the 4 lysine residues identified as the ubiquitination sites in Rod1 (38, 67) produced hypomorphic alleles with greater retention of Hxt1 and Hxt3 at the PM and increased resistance to 2DG. Our results are in marked contrast to earlier studies, which reported that these sites were required for Rod1-mediated endocytosis of the lactate permease Jen1 (38) . In agreement with our findings, however, ubiquitination of Rod1 is not required for its function in Ste2 internalization (67) . Binding of Rsp5 by Rod1 is required for the internalization of Hxt1 and Hxt3 as well as for that of other PM targets that undergo Rod1-dependent internalization, including Jen1 (38) and Ste2 (67) . Mutation of the PPXY motifs in Rod1 and Rog3 eliminated their ability to support the endocytosis of Hxt1 and Hxt3 in response to 2DG and failed to restore 2DG sensitivity to rod1⌬ rog3⌬ cells. In addition, Rsp5 activity is required for the 2DG-induced endocytosis of Hxt1 and Hxt3, in agreement with recent reports showing that Rsp5 is critical for the downregulation of Hxt1 and Hxt3 upon nutrient starvation (32, 33) . Thus, it seems likely that in response to 2DG, ␣-arrestin recruitment of Rsp5 stimulates Hxt ubiquitination, endocytosis, and trafficking to the vacuole (Fig. 9A) .
The internalization of other glucose transporters, such as the high-affinity glucose transporter Hxt6, is also regulated by Rod1, which is internalized upon a shift from raffinose to glucose (42) . Although the regulatory cues here have not been defined, loss of Snf1-mediated inhibition of Rod1 is plausible because addition of glucose leads to reduced Snf1 activity (58) . While Hxt6 internalization is mediated by Rod1 in response to the carbon source, another ␣-arrestin, Csr2/Art8, regulates Hxt6 endocytosis in response to cycloheximide stress (42) . In accordance with some functional redundancy between Rod1 and Csr2, we observed weak restoration of Hxt1 and Hxt3 trafficking to the vacuole in 9Arr⌬ cells complemented with Csr2 (Fig. 5E ). Also, Csr2 was implicated in studies of Hxt3 downregulation in response to a glucose-toethanol shift, whereas Rod1 made little contribution (and Rog3 was not tested) (33) . The internalization of Hxt3 upon a shift to ethanol requires Ras2 and TORC1 but not Snf1 (33) . Thus, it appears that different signaling cues dictate the activities of specific ␣-arrestins under distinctive nutrient conditions, thereby determining the PM residence times of particular hexose transporters (42) .
Like Rod1, Rog3 required Rsp5 recruitment to mediate Hxt3 endocytosis and confer sensitivity to 2DG. Mutation of the (V/ P)PXY motifs in Rog3, which are required for its binding to Rsp5 (67) , completely eliminated the Rog3-dependent internalization of Hxt3 and failed to restore 2DG sensitivity to rod1⌬ rog3⌬ cells. As with Rod1, a Rog3 allele (rog3-4KR) was also hypomorphic, suggesting that ubiquitination of Rog3 may not be needed for its optimal function in Hxt3 trafficking (Fig. 9C) . However, in several other respects, Rog3 exhibited a pattern of regulation in response to 2DG different from that displayed by Rod1. In contrast to Rod1, it is unclear if Rog3 is a Snf1 substrate. Rog3 is phosphorylated in glucose-grown cells and in response to 2DG addition, yet this phosphorylation does not appear to be dependent on Snf1. Interestingly, the abundance of Rog3 is under complex regulation; in response to 2DG, when Snf1 is modestly activated, Rog3 levels increase. In reg1⌬ cells, when Snf1 is hyperactive, Rog3 is nearly undetectable. The low abundance of Rog3 in reg1⌬ cells is due to the hyperactivation of Snf1, as evidenced by the fact that Rog3 levels were restored in reg1⌬ snf1⌬ cells. These results demonstrate that Rog3 expression and/or stability is controlled by Snf1.
It is tempting to speculate that Rog3 may be regulated in a fashion analogous to that of the mammalian ␣-arrestin TXNIP. In mammalian cells, TXNIP is required for the endocytosis of the glucose transporter GLUT1, and the phosphorylation of TXNIP by AMPK targets it for degradation, thereby preventing GLUT1 internalization (27) . Moreover, when present, TXNIP somehow reduces the level of GLUT1 mRNA (27) . If Rog3 has a similar additional regulatory role, it might explain the changes in HXT expression that we observed in 2DG-treated and/or reg1⌬ cells. However, 2DG treatment activates AMPK in mammalian cells, Under high-glucose conditions, the phosphorylation of Rod1 by Snf1 inhibits its trafficking function. In response to 2DG, Rod1 ubiquitination increases, promoting the internalization of hexose transporters, suggesting that an alternative, Snf1-counterbalancing pathway, such as the Reg1/Glc7 phosphatase, must also be activated by 2DG (black arrows). (C) Rog3 regulation and posttranslational modifications. In response to 2DG, Rog3 protein levels, and possibly Rog3 ubiquitination, are increased. In the absence of Reg1, Snf1 kinase hyperactivation promotes Rog3 degradation.
leading to TXNIP degradation (27) , whereas the hyperactivation of Snf1 observed in reg1⌬ yeast cells promoted the loss of Rog3 accumulation. Hence, the analogy between TXNIP and Rog3 is imperfect.
As shown here and in recent related work (7), Snf1 has some activity under high-glucose conditions and exhibits substrate selectivity that defines an unexpected role for Snf1 in regulating the 2DG sensitivity of glucose-grown cells. Although Snf1 is definitely less active when cells are growing in a high-glucose medium than in a low-glucose medium (7, 58) , the enzyme clearly retains physiologically important activity, because snf1⌬ cells are more sensitive to 2DG than wild-type cells. In glucose-grown cells, a low level of T120 phosphorylation can be detected (7), and active Snf1 has been found in other studies of cells growing on glucose (58, 64, (78) (79) (80) . Snf1 activity is required for resistance to 2DG, and its phosphorylation on T210 increases in response to 2DG addition (7) . Likewise, mammalian AMPK is activated by 2DG (27) , suggesting that yeast and mammals share a conserved 2DG stress response. Glucose starvation causes robust activation of Snf1 and hyperphosphorylation of the transcriptional repressor Mig1 (59, 81) ; in contrast, 2DG-induced activation of Snf1 is modest yet sufficient for the increased phosphorylation of Rod1 but not of Mig1 (7) . These observations raise the possibility that distinct signaling cues modulate Snf1 activity selectively, directing Snf1 toward distinct substrates.
Our findings lead us to propose that instead of acting as a binary off-on regulator of its downstream effectors, Snf1 acts more as a cellular rheostat, responsive to even subtle changes in the energy state of the cell and able to fine-tune the cellular response by selectively targeting its activity to specific substrates. In support of this proposal, Snf1 is activated by sodium stress in glucose-grown cells and is required for the sodium stress response (82) ; however, Mig1 is not phosphorylated in response to sodium stress (79) . The identity of the critical Snf1 substrate(s) for sodium stress response is not known. Thus, the degree to which Snf1 is activated, the specific isoform that is activated, and the localization of the activated kinase or the stimulus that triggers Snf1 activation may all play roles in dictating the substrates that Snf1 phosphorylates. The molecular details of this selective Snf1 targeting remain to be elucidated but will undoubtedly provide exciting new insights into critical control of cellular signaling.
